Jason Sheasby is a nationally recognized trial lawyer and partner at Irell & Manella LLP, widely regarded as one of the country’s leading intellectual property litigators. Over the past two years alone, he has taken more than ten complex, high-stakes matters to trial — securing victories in each. Sheasby was named Litigator of the Year by The American Lawyer (2024) for a string of landmark wins involving cutting-edge patent and commercial disputes. His courtroom successes include multiple nine-figure verdicts in cases involving computer memory technology, data storage systems, medical devices, and antiviral pharmaceuticals. Among his recent victories: Secured $240 million verdict for StreamScale Achieved $118 million verdict for Netlist Obtained $142 million damages award in G+ Communications retrial Won complete defense for Gilead in high-stakes royalty arbitration Secured $59.5 million verdict and permanent injunction for DePuy Synthes Sheasby’s litigation practice spans patent infringement, contract disputes, trade secrets, and high-technology matters involving semiconductors, medical devices, pharmaceuticals, and AI-driven technologies. In addition to his legal practice, Sheasby serves on the Board of Trustees of Pomona College and is a founder of TORL Biotherapeutics, a biotechnology company focused on advancing next-generation cancer therapeutics. A graduate of Pomona College (Phi Beta Kappa, summa cum laude) and Harvard Law School (cum laude), Sheasby combines academic rigor with courtroom precision.